518 related articles for article (PubMed ID: 19289451)
1. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
[TBL] [Abstract][Full Text] [Related]
2. To treat or not to treat perinatal depression with antidepressant medication: effects on infant growth.
Parry BL
Am J Psychiatry; 2013 May; 170(5):453-4. PubMed ID: 23511843
[No Abstract] [Full Text] [Related]
3. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
4. Does fetal exposure to SSRIs or maternal depression impact infant growth?
Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
[TBL] [Abstract][Full Text] [Related]
5. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
6. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
Malm H; Klaukka T; Neuvonen PJ
Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
[TBL] [Abstract][Full Text] [Related]
7. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
8. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
11. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Grzeskowiak LE; Gilbert AL; Morrison JL
J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
[TBL] [Abstract][Full Text] [Related]
12. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.
Cornet MC; Wu YW; Forquer H; Avalos LA; Sriram A; Scheffler AW; Newman TB; Kuzniewicz MW
Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):294-300. PubMed ID: 38071585
[TBL] [Abstract][Full Text] [Related]
13. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.
Hwang YM; Roper RT; Piekos SN; Enquobahrie DA; Hebert MF; Paquette AG; Baloni P; Price ND; Hood L; Hadlock JJ
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2313364. PubMed ID: 38342572
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
15. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
16. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
17. Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
Vlenterie R; van Gelder MMHJ; Anderson HR; Andersson L; Broekman BFP; Dubnov-Raz G; El Marroun H; Ferreira E; Fransson E; van der Heijden FMMA; Holzman CB; Kim JJ; Khashan AS; Kirkwood BR; Kuijpers HJH; Lahti-Pulkkinen M; Mason D; Misra D; Niemi M; Nordeng HME; Peacock JL; Pickett KE; Prady SL; Premji SS; Räikkönen K; Rubertsson C; Sahingoz M; Shaikh K; Silver RK; Slaughter-Acey J; Soremekun S; Stein DJ; Sundström-Poromaa I; Sutter-Dallay AL; Tiemeier H; Uguz F; Varela P; Vrijkotte TGM; Winterfeld U; Zar HJ; Zervas IM; Prins JB; Pop-Purceleanu M; Roeleveld N
Obstet Gynecol; 2021 Oct; 138(4):633-646. PubMed ID: 34623076
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Lund N; Pedersen LH; Henriksen TB
Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of prenatal antidepressant exposure.
Simon GE; Cunningham ML; Davis RL
Am J Psychiatry; 2002 Dec; 159(12):2055-61. PubMed ID: 12450956
[TBL] [Abstract][Full Text] [Related]
20. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
